Hot Medical Stocks To Own Right Now


Several days ago Fitbit (FIT) and Dexcom (DXCM) announced they are partnering to develop CGM (continuous glucose monitoring) solutions for people living with diabetes. The first product will incorporate DXCM’s CGM data and bridge it with FIT’s new Ionic watch. Users of Android and iOS devices would be able to see “activity and glucose levels, right on their wrist.”

So what’s the big deal?

Th truth is that it isn’t such a big deal for DXCM. The company already sells and markets a similar product for both Android and iOS devices.

However, please note that the Ionic will have four days of battery life, which could be considered mission critical in such medical applications. Apple’s (AAPL) new iWatch 3 on the other hand clams to have up to 18 hours of battery life.

Also, the Ionic smartwatch has a built-in GPS tracker, an optical heart rate sensor, an accelerometer and a blood oxygen sensor. So perhaps DXCM and FIT might have more plans for medical Apps in the future. The AAPL iWatch does not have all those amenities, and to get the GPS tracker you have to fork out about $30 more.

Hot Medical Stocks To Own Right Now: Globalstar Inc.(GSAT)


Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday morning, the telecommunication services shares rose 1.06 percent. Meanwhile, top gainers in the sector included Globalstar, Inc. (NYSE: GSAT), up 5 percent, and Partner Communications Company Ltd. (NASDAQ: PTNR) up 4 percent.

  • [By Max Byerly]

    Globalstar (NYSEAMERICAN:GSAT) saw a significant growth in short interest in April. As of April 13th, there was short interest totalling 86,799,863 shares, a growth of 6.9% from the March 30th total of 81,207,186 shares. Based on an average daily volume of 6,541,037 shares, the short-interest ratio is currently 13.3 days. Approximately 14.4% of the shares of the stock are short sold.

  • [By Anders Bylund]

    Shares of Globalstar Inc. (NYSEMKT:GSAT) went on a roller coaster ride this morning. The satellite communications specialist’s stock bottomed out in a 16% drop just after 10 a.m. EDT, recovering to a less dramatic 7% decline an hour later. The company is the target of a complicated merger deal today, and investors on the open market are not loving the idea.

  • [By Paul Ausick]

    Globalstar Inc. (NYSEAMERICAN: GSAT) traded down about 5.9% Monday and posted a new 52-week low of $0.48 after closing Friday at $0.51. The stock’s 52-week high is $2.30. Volume totaled about 4.4 million, about 20% below the daily average of around 5.4 million. The company had no specific news.

  • [By Paul Ausick]

    Globalstar Inc. (NYSEAMERICAN: GSAT) traded down about 2% Friday and posted a new 52-week low of $0.49 after closing Thursday at $0.50. The stock’s 52-week high is $2.30. Volume totaled about 4.2 million, almost 20% below the daily average of around 5.4 million. The company had no specific news.

Hot Medical Stocks To Own Right Now: Emerson Electric Company(EMR)

Advisors’ Opinion:

  • [By Max Byerly]

    Flippin Bruce & Porter Inc. decreased its holdings in Emerson Electric (NYSE:EMR) by 33.6% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 66,251 shares of the industrial products company’s stock after selling 33,574 shares during the quarter. Flippin Bruce & Porter Inc.’s holdings in Emerson Electric were worth $4,525,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Shane Hupp]

    Element Capital Management LLC acquired a new stake in Emerson Electric Co. (NYSE:EMR) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 202,986 shares of the industrial products company’s stock, valued at approximately $13,864,000.

  • [By Logan Wallace]

    D.A. Davidson & CO. lifted its position in shares of Emerson Electric (NYSE:EMR) by 1.3% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 574,584 shares of the industrial products company’s stock after buying an additional 7,640 shares during the period. Emerson Electric makes up about 0.8% of D.A. Davidson & CO.’s holdings, making the stock its 25th biggest holding. D.A. Davidson & CO.’s holdings in Emerson Electric were worth $39,244,000 at the end of the most recent reporting period.

Hot Medical Stocks To Own Right Now: Luby's, Inc.(LUB)


Advisors’ Opinion:

  • [By Max Byerly]

    Headlines about Luby’s (NYSE:LUB) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Luby’s earned a news impact score of 0.10 on Accern’s scale. Accern also gave news coverage about the restaurant operator an impact score of 47.2262144037183 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Joseph Griffin]

    Main Street Capital (NYSE: MAIN) and Luby’s (NYSE:LUB) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation and risk.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
    Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
    Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
    Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
    Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
    Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
    Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
    Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
    Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
    Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent

Hot Medical Stocks To Own Right Now: HSBC Holdings PLC (HSBA)


Advisors’ Opinion:

  • [By Joseph Griffin]

    HSBC (LON:HSBA) had its target price lowered by equities research analysts at Shore Capital from GBX 721 ($9.60) to GBX 625 ($8.32) in a report issued on Tuesday. The brokerage presently has a “sell” rating on the financial services provider’s stock. Shore Capital’s price objective indicates a potential downside of 14.71% from the company’s previous close.

  • [By Ethan Ryder]

    HSBC (LON:HSBA) had its price target dropped by equities research analysts at Citigroup from GBX 810 ($10.78) to GBX 800 ($10.65) in a report released on Tuesday. The brokerage currently has a “buy” rating on the financial services provider’s stock. Citigroup’s price target points to a potential upside of 9.59% from the stock’s previous close.

Leave a Reply

Your email address will not be published.